ArticleInternational journal of general medicine2025
Translational Insights into Cancer-Associated Fibroblast Infiltration-Related Biomarkers in Glioblastoma and Their Clinical Prognostic Value.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Cancer-associated fibroblasts (CAFs) could promote the progression and migration of tumors. However, the roles of CAFs infiltration related genes in glioblastoma (GBM) were still unclear. Methods: GBM-related transcriptome data and clinical information were downloaded from the UCSC Xena and CGGA databases. In this study, the abundance of fibroblasts were calculated by "MCPcounter", and the CAFs infiltration related genes were identified by "WGCNA". Then, the biomarkers of GBM were screened out, and based on it, the survival risk model (risk score) and the prognostic model (nomogram) were constructed to clinical predict the survival of GBM. Moreover, the function and mutation analyses were performed to further study the mechanisms of GBM. Furthermore, the competitive endogenous RNAs (ceRNA) regulatory network were used to reveal the potential regulation of biomarkers. Results: Totals of 46 CAFs infiltration related genes were associated with focal adhesion. Four biomarkers, including STC1, BDKRB2, SOCS3 and FURIN were identified, and all of them were negative factors. Nomogram constructed based on risk scores and clinical indicators had good predictive performance (AUC > 0.68). Noticeable, COL5A1 might be the key gene, which were extremely positively associated with all these four biomarkers. Besides, the genes in high-risk groups were associated with the functions of epithelial mesenchymal transition (EMT) and angiogenesis. In addition, hsa-miR-107 could regulate STC1 through the TGF-β signaling pathway and further regulating the migration and invasion of tumour. Conclusion: This study identified four CAFs infiltration related biomarkers associated with the prognosis of GBM. This finding might help to deepen the understanding the roles of CAFs in development of GBM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.